Dowling & Yahnke’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $15.5M | Sell |
94,777
-748
| -0.8% | -$127K | 0.72% | 32 |
|
|
2022
Q2 | $17M | Buy |
95,525
+1,871
| +2% | +$333K | 0.8% | 29 |
|
|
2022
Q1 | $16.6M | Sell |
93,654
-6,126
| -6% | -$1.04M | 0.72% | 30 |
|
|
2021
Q4 | $17.1M | Sell |
99,780
-4,647
| -4% | -$761K | 0.82% | 26 |
|
|
2021
Q3 | $16.9M | Sell |
104,427
-1,074
| -1% | -$183K | 0.93% | 24 |
|
|
2021
Q2 | $17.4M | Buy |
105,501
+297
| +0.3% | +$49.2K | 1% | 22 |
|
|
2021
Q1 | $17.3M | Sell |
105,204
-15
| -0% | -$2.43K | 1.18% | 14 |
|
|
2020
Q4 | $16.6M | Buy |
105,219
+6,586
| +7% | +$972K | 1.18% | 17 |
|
|
2020
Q3 | $14.7M | Buy |
98,633
+33
| +0% | +$4.88K | 1.18% | 17 |
|
|
2020
Q2 | $13.9M | Buy |
98,600
+1,925
| +2% | +$281K | 1.16% | 15 |
|
|
2020
Q1 | $12.7M | Sell |
96,675
-1,888
| -2% | -$268K | 1.22% | 15 |
|
|
2019
Q4 | $14.4M | Sell |
98,563
-58
| -0.1% | -$7.87K | 1.1% | 16 |
|
|
2019
Q3 | $12.8M | Buy |
98,621
+1,513
| +2% | +$199K | 1.06% | 19 |
|
|
2019
Q2 | $13.5M | Buy |
97,108
+290
| +0.3% | +$40.1K | 1.12% | 16 |
|
|
2019
Q1 | $13.5M | Buy |
96,818
+6,049
| +7% | +$810K | 1.3% | 12 |
|
|
2018
Q4 | $13.3M | Buy |
90,769
+1,899
| +2% | +$265K | 1.38% | 11 |
|
|
2018
Q3 | $12.3M | Buy |
88,870
+11,715
| +15% | +$1.56M | 1.07% | 16 |
|
|
2018
Q2 | $9.36M | Sell |
77,155
-512
| -0.7% | -$63.9K | 0.87% | 25 |
|
|
2018
Q1 | $9.95M | Sell |
77,667
-996
| -1% | -$135K | 0.93% | 20 |
|
|
2017
Q4 | $11M | Sell |
78,663
-46
| -0.1% | -$6.41K | 0.99% | 16 |
|
|
2017
Q3 | $10.2M | Sell |
78,709
-576
| -0.7% | -$76.4K | 1.04% | 17 |
|
|
2017
Q2 | $10.5M | Sell |
79,285
-520
| -0.7% | -$66.3K | 1.1% | 13 |
|
|
2017
Q1 | $9.94M | Sell |
79,805
-14
| -0% | -$1.67K | 1.06% | 15 |
|
|
2016
Q4 | $9.2M | Sell |
79,819
-991
| -1% | -$114K | 1.03% | 18 |
|
|
2016
Q3 | $9.55M | Sell |
80,810
-620
| -0.8% | -$75.2K | 1.12% | 16 |
|
|
2016
Q2 | $9.88M | Buy |
81,430
+5,482
| +7% | +$623K | 1.19% | 12 |
|
|
2016
Q1 | $8.22M | Buy |
75,948
+1,350
| +2% | +$140K | 1.01% | 21 |
|
|
2015
Q4 | $7.66M | Buy |
74,598
+205
| +0.3% | +$20.6K | 0.96% | 22 |
|
|
2015
Q3 | $6.95M | Sell |
74,393
-370
| -0.5% | -$35.8K | 0.95% | 20 |
|
|
2015
Q2 | $7.29M | Buy |
74,763
+1,236
| +2% | +$124K | 0.92% | 18 |
|
|
2015
Q1 | $7.4M | Sell |
73,527
-348
| -0.5% | -$35.4K | 0.92% | 17 |
|
|
2014
Q4 | $7.72M | Buy |
73,875
+239
| +0.3% | +$25.2K | 0.96% | 18 |
|
|
2014
Q3 | $7.85M | Sell |
73,636
-2,861
| -4% | -$297K | 1.03% | 17 |
|
|
2014
Q2 | $8M | Sell |
76,497
-4,448
| -5% | -$450K | 1.03% | 17 |
|
|
2014
Q1 | $7.95M | Buy |
80,945
+5,374
| +7% | +$498K | 1.05% | 15 |
|
|
2013
Q4 | $6.92M | Buy |
75,571
+4,795
| +7% | +$442K | 0.97% | 21 |
|
|
2013
Q3 | $6.14M | Buy |
70,776
+1,488
| +2% | +$133K | 0.96% | 20 |
|
|
2013
Q2 | $5.95M | Buy |
+69,288
| New | +$5.88M | 0.99% | 20 |
|
Other funds holding JNJ
Dowling & Yahnke's JNJ Position: Q3 2022 in Review
Dowling & Yahnke reduced its Johnson & Johnson (JNJ) stake by 0.78% in Q3 2022, selling an estimated $127K and leaving 94,777 shares worth $15.5M. The position accounts for 0.72% of the portfolio, ranked #32.
Dowling & Yahnke first reported a position in JNJ in Q2 2013 and has held it in 38 quarters since. The position peaked at $17.4M in Q2 2021. 3,623 funds tracked by Wall St. Rank hold JNJ as of Q3 2022.
- Dowling & Yahnke held 94,777 shares of Johnson & Johnson worth $15.5M as of Q3 2022.
- Dowling & Yahnke sold 748 Johnson & Johnson shares in Q3 2022, an estimated $127K.
- Johnson & Johnson made up 0.72% of Dowling & Yahnke's portfolio in Q3 2022, its #32 holding.
- Dowling & Yahnke first reported a position in Johnson & Johnson in Q2 2013 and has held it in 38 quarters since.
- Dowling & Yahnke's Johnson & Johnson position peaked at $17.4M in Q2 2021.
- 3,623 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2022.
Based on Dowling & Yahnke's 13F filing for Q3 2022, filed 3 Nov 2022.